marijuana stocks

Form 8-K for LEXARIA CORP.


24-Aug-2015

Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure.A copy of the news release announcing the Company’s technology achieves Cannabidiol absorption rate 499% greater than baseline in laboratory testing filed as exhibit 99.1 to this current report and is hereby incorporated by reference.

 


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Nabis Holdings (OTC: NABIF) (CSE: NAB) Announces Upsize of Previously Announced Debenture Unit Private Placement Offering to C$35 Million

VANCOUVER, British Columbia, March 07, 2019 (GLOBE NEWSWIRE) — Nabis Holdings (CSE:NAB;…

Canopy Growth Corporation (CGC) Announces Upsized US$35 Million Private Placement

Canopy Growth Announces Upsized US$35 Million Private Placement Canopy Growth Corporation (“Canopy…

Innovative Industrial Properties (IIPR) Goodness Growth Holdings Announces Sale-Leaseback Transaction in New York with IIP

Goodness Growth Holdings Announces Sale-Leaseback Transaction in New York with Innovative Industrial…

Lexaria Bioscience Corp. (LXRP) (LXX.CN) Commercial Launch of ChrgD+ Odorless, Flavorless, Water-Soluble Powdered Hemp Oil

Lexaria Announces Commercial Launch of ChrgD+ Odorless, Flavorless, Water-Soluble Powdered Hemp Oil…